Assessment of the Risk of Exposure to vCJD Infectivity in Blood and Blood Products Draft Report for the Spongiform Encephalopathy Advisory Committee and the Department of Health, Det Norske Veritas, 1998. Assesses the risk of vCJD in the blood. Identifies groups of patients most at risk. Considers the effectiveness of possible measures to reduce the risk. Concludes patients receiving red blood cells, platelets or plasma are most exposed as these products may be able to cause infection.